MAPT and Alzheimer disease: For example, icariin can enhance the expression of IGF and BDNF, thereby activating the PI3K/AKT pathway, inhibiting Aβ production and tau protein phosphorylation, and alleviating symptoms in AD animal models (Wang et al., 2012).